The Bcl-2 inhibitor Venetoclax promotes CLL cell apoptosis (39), and induces rapid and pronounced activation and mitochondrial translocation of Bax in cell lines of acute myeloid leukemia (40). The gene discussed is BAX; the disease is B-cell chronic lymphocytic leukemia.